1 unchanged sentence
Incorporation by Reference
−Removed: Form of Common Warrant
−Removed: June 30, 2025
−Removed: Form of Pre-Funded Warrant
−Removed: June 30, 2025
−Removed: Form of Representative Warrant
−Removed: June 30, 2025
−Removed: Form of Warrant Agency Agreement
−Removed: June 30, 2025
−Removed: Inducement Letter in consideration for Exercise of the Common Stock Purchase Warrants issued on October 25, 2022, July 21, 2024 and July 2, 2025
−Removed: October 10, 2025
−Removed: Form of Series I Common Stock Purchase Warrant
−Removed: October 10, 2025
−Removed: Form of Series II Common Stock Purchase Warrant
−Removed: October 10, 2025
+Added: Amended and Restated By-Laws of Cellectar Biosciences, Inc., effective as of March 11, 2025
+Added: March 17, 2025
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
5 unchanged sentences
CELLECTAR BIOSCIENCES, INC.
−Removed: November 13, 2025
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: November 13, 2025
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.